CBV (chemotherapy)
CBV (Chemotherapy)
CBV (pronounced as C-B-V), is a chemotherapy regimen used primarily in the treatment of Hodgkin's lymphoma. The acronym CBV stands for the three drugs that make up the regimen: Cyclophosphamide, Bleomycin, and Vinblastine.
Pronunciation
CBV is pronounced as "C-B-V", with each letter pronounced separately.
Etymology
The term CBV is an acronym derived from the initial letters of the three drugs used in the regimen: Cyclophosphamide, Bleomycin, and Vinblastine.
Related Terms
- Cyclophosphamide: An immunosuppressive drug used most commonly in chemotherapy. It is a prodrug that is converted in the body to its active form.
- Bleomycin: A medication used for the treatment of several types of cancer including Hodgkin's lymphoma, testicular cancer, and ovarian cancer.
- Vinblastine: A chemotherapy medication used to treat a number of types of cancer including Hodgkin's lymphoma, non-small cell lung cancer, bladder cancer, brain cancer, and testicular cancer.
Usage
The CBV regimen is used primarily in the treatment of Hodgkin's lymphoma. It is a combination of three drugs: Cyclophosphamide, Bleomycin, and Vinblastine. Each of these drugs works in a different way to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.
Side Effects
Like all chemotherapy regimens, CBV can have side effects. These can include nausea, vomiting, hair loss, and a decrease in blood cells which can lead to an increased risk of infection, bleeding problems, tiredness, and breathlessness.
External links
- Medical encyclopedia article on CBV (chemotherapy)
- Wikipedia's article - CBV (chemotherapy)
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski